Incyte (INCY) Net Income (2010 - 2026)
Incyte's (INCY) quarterly Net Income came in at $585.6 million in Q2 2026, up 44.59% on a YoY basis from $405.0 million in Q2 2025, and up 93.06% quarter-over-quarter from $303.3 million in Q1 2026.
Analysis
Incyte (INCY) Net Income (2010 - 2026) Analysis & Trends
Incyte (INCY) has reported Net Income for 17 consecutive years, with $585.6 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Net Income rose 44.59% year-over-year to $585.6 million; the trailing twelve-month figure through Jun 2026 stood at $1.6 billion (up 85.15% YoY), and the FY2025 full-year result was $1.3 billion, up 3844.96% from the prior year.
- Net Income grew to $585.6 million in Q2 2026 per INCY's latest filing, from $303.3 million in the prior quarter.
- Across five years, Net Income topped out at $585.6 million in Q2 2026 and bottomed at -$444.6 million in Q2 2024.
- Historically, Net Income has averaged $174.8 million across 5 years, with a median of $170.4 million in 2023.
- The widest YoY moves for Net Income: up 681.22% in 2024, down 318.43% in 2024.
- Over 5 years, Net Income stood at $28.5 million in 2022, then soared by 606.51% to $201.1 million in 2023, then increased by 0.07% to $201.2 million in 2024, then jumped by 48.74% to $299.3 million in 2025, then soared by 95.67% to $585.6 million in 2026.
- According to Business Quant data, Net Income over the past three periods registered $585.6 million, $303.3 million, and $299.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 5.28 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | -238.00 Mn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 2.16 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | -644.37 Mn |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn | 237.01 Mn |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 585.61 Mn |
| 10 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | 333.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 585.61 Mn |
| Mar 31, 2026 | 303.33 Mn |
| Dec 31, 2025 | 299.28 Mn |
| Sep 30, 2025 | 424.17 Mn |
| Jun 30, 2025 | 405.00 Mn |
| Mar 31, 2025 | 158.20 Mn |
| Dec 31, 2024 | 201.21 Mn |
| Sep 30, 2024 | 106.46 Mn |
| Jun 30, 2024 | -444.60 Mn |
| Mar 31, 2024 | 169.55 Mn |
| Dec 31, 2023 | 201.08 Mn |
| Sep 30, 2023 | 171.27 Mn |
| Jun 30, 2023 | 203.55 Mn |
| Mar 31, 2023 | 21.70 Mn |
| Dec 31, 2022 | 28.46 Mn |
| Sep 30, 2022 | 112.78 Mn |
| Jun 30, 2022 | 161.43 Mn |
| Mar 31, 2022 | 37.99 Mn |
| Dec 31, 2021 | 563.86 Mn |
| Sep 30, 2021 | 181.74 Mn |